The Accessioning Unit and Biorepository serves as a central point for receipt, processing, storage and distribution of biomaterials from supported projects and has state of the art physical and electronic space. All samples are recorded in a computerized inventory system based on Frontier Science’s Laboratory Data Management System (LDMS) and the Accessioning Unit employs a workflow that ensures checks for compliance (IRB/IACUC) and executed material transfer agreements (MTA) prior to specimen release. The Accessioning Unit and Biorepository operates in a Good Clinical Laboratory Practice (GCLP) environment under oversight from Quality Assurance Duke Immunogenicity Immunology Programs (QADVIP). All Accessioning Unit and Biorepository staff that prepare materials for shipping are trained in International Air Transport Association (IATA) regulations.
All physical materials are stored in 4°C, -20°C, -80°C, and LN2 cold storage units in the Biorepository and connected to an automated, web-accessible and auditable temperature monitoring system (Minus80 Monitoring). The Biorepository currently has two 4°C, and one -20°C, twenty-seven -80°C, and nineteen LN2 cold storage units. The Biorepository cold storage units house 650,000 vials at 4°C, -20°C, and -80°C and 150,000 vials in LN2. The Biorepository currently has the capability of adding 40,000 vials at 4°C, -20°C, and -80°C and 20,000 in LN2.